Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 451–500 of 6,256 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04211675	NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab(STING)	active not recruiting	Phase 1 / Phase 2	31	Nationwide Children's HospitalOTHER	1	Sep 16, 2026	clinicaltrials
NCT04390724	Optimizing Y90 Therapy for Radiation Lobectomy	active not recruiting	—	104	Northwestern UniversityOTHER	1	Sep 16, 2026	clinicaltrials